文献速递中毒与环境急症重症综合管理与镇静镇痛

氧化应激是否参与急性有机磷中毒的毒性?系统评价

Does oxidative stress contribute to toxicity in acute organophosphorus poisoning? - a systematic review of the evidence.
PubMed 文献 · Clin Toxicol (Phila) · 2019-12-06
一句话结论急性有机磷自杀中毒中存在氧化损伤证据,但标志物弱、异质性大;乙酰半胱氨酸在动物中可能有益,两项小型人体试验仅显示减少阿托品需求、未改善临床结局,不足以支持常规使用。

该系统评价检索PubMed、EMBASE、MEDLINE和Cochrane数据库,最终纳入17项研究,包括11项人体观察性研究、4项动物干预研究和2项人体干预研究。人体研究均报告脂质和蛋白氧化损伤,但所用脂质过氧化标志物较弱、研究间结果与质量异质性大、涉及有机磷杀虫剂种类差异明显。动物研究显示抗氧化剂可改善氧化损伤标志物或抗氧化活性,一项小鼠研究显示乙酰半胱氨酸200 mg/kg使丙二醛降低35%、生存率提高60%以上。两项小型随机对照试验显示乙酰半胱氨酸作为标准治疗辅助可分别减少阿托品需求77%和55%,但未影响临床相关结局。作者认为两项人体研究样本量太小,不足以支持乙酰半胱氨酸用于有机磷中毒,需进一步研究机制并开展大型明确临床试验后方可常规使用。

要点

  • 11项人体研究均报告急性有机磷中毒后脂质和蛋白氧化损伤,但所用脂质过氧化标志物较弱。
  • 两项病例对照研究中红细胞膜丙二醛浓度病例组较对照组分别高380%和160%。
  • 三项病例对照研究中血浆丙二醛浓度病例组较对照组高约63%;一项前瞻性研究中中重度中毒患者血浆丙二醛较基线无显著升高。
  • 一项小鼠研究显示乙酰半胱氨酸200 mg/kg使丙二醛降低35%、生存率提高60%以上。
  • 两项小型随机对照试验显示乙酰半胱氨酸辅助标准治疗使阿托品需求分别减少77%和55%,但未影响临床相关结局。

适用人群与场景

  • 急性有机磷杀虫剂自杀中毒患者(人体观察性研究和两项人体随机对照试验的纳入人群)。
  • 排除慢性有机磷中毒、使用无抗氧化作用药物以及与氧化应激无关的研究对象。

处置流程与药物剂量

  • 两项小型随机对照试验中,乙酰半胱氨酸作为急性有机磷中毒标准治疗的辅助用药;原文未报告具体剂量、给药途径和疗程。
  • 一项小鼠研究中乙酰半胱氨酸200 mg/kg给药使丙二醛降低35%、生存率提高60%以上。

研究设计与关键结果

  • 系统评价共检索到256条结果,纳入17项研究:人体观察性研究11项、动物干预研究4项、人体干预研究2项。
  • 11项人体研究均报告脂质和蛋白氧化损伤;9项研究中8项报告脂质过氧化弱标志物丙二醛不同程度升高。
  • 两项病例对照研究中红细胞膜丙二醛浓度病例组较对照组分别高380%和160%。
  • 三项病例对照研究中血浆丙二醛浓度病例组较对照组高约63%;一项前瞻性研究中中重度中毒患者血浆丙二醛较基线无显著升高。
  • 五项病例对照研究测定硫醇残基作为蛋白氧化损伤标志物,中毒后变化不一;唯一一项研究未发现氧化性DNA损伤证据。
  • 4项动物研究经抗氧化剂治疗后均显示氧化损伤标志物或抗氧化活性改善;一项偏倚风险较低的小鼠研究显示乙酰半胱氨酸200 mg/kg使丙二醛降低35%、生存率提高60%以上。
  • 两项小型随机对照试验显示乙酰半胱氨酸辅助标准治疗使阿托品需求分别减少77%和55%,但未影响临床相关结局。

证据类型、等级与局限

  • 证据类型:系统评价,纳入人体观察性研究11项、动物干预研究4项、人体随机对照试验2项。
  • 人体研究中脂质过氧化标志物较弱,研究间结果与质量异质性大,所涉有机磷杀虫剂种类差异明显。
  • 两项人体随机对照试验样本量太小,不足以提供支持乙酰半胱氨酸用于有机磷中毒的明确证据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,动物数据提示抗氧化剂可减轻急性中毒的不良效应,提示氧化应激可能直接造成临床损害。
  • 作者认为,乙酰半胱氨酸在动物研究中的获益可能通过增加内源性解毒剂谷胱甘肽合成而非直接抗氧化作用介导。
  • 作者认为,两项人体临床研究样本量太小,不足以支持乙酰半胱氨酸用于有机磷中毒。
  • 作者认为,在抗氧化剂可常规用于治疗之前,需进一步研究急性有机磷中毒中氧化应激的机制,并开展大型明确的抗氧化剂临床试验。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Introduction: Organophosphorus (OP) insecticide self-poisoning is a global problem, killing tens of thousands of people every year. Oxidative stress has been proposed to play a pathological role in OP poisoning, but whether it plays a direct toxic role is currently unclear.Objectives: To determine whether there is consistent evidence of oxidative stress in patients with acute OP insecticide self-poisoning, and whether there are animal or human trial data that indicate that treatment of oxidative stress provides clinical benefit, which would suggest a direct toxic effect of oxidative stress.Methods: We conducted a systematic review using the PubMed, EMBASE and MEDLINE databases, and the Cochrane Database of Systematic reviews, based upon the following search terms and keywords: "organophosphate poisoning", "oxidative stress" and "antioxidant". All articles relevant to the aims of the study were included. Articles related to chronic OP poisoning, to use of medicines without antioxidant benefits, or to subjects other than oxidative stress were excluded. The search returned 256 results of which 17 studies were considered relevant and grouped under the following categories: observational human studies (n = 11) and intervention studies in animals (n = 4) and humans (n = 2).Oxidative stress markers in human studies: Oxidative damage to lipids and proteins was reported in all eleven human studies. Eight of nine studies reported variable increases in a weak marker of lipid peroxidation, malondialdehyde. In two case-control studies, erythrocyte membrane malondialdehyde concentrations were 380% and 160% higher in cases than controls, while plasma malondialdehyde concentrations were ∼63% higher in cases than controls in three case-control studies. In a prospective study, plasma malondialdehyde did not increase significantly from baseline in moderate or severely poisoned patients. Five case-control studies measured thiol residues as markers of protein oxidative damage and found variable changes after poisoning. No evidence of oxidative DNA damage was found in the one study that investigated it.Antioxidant intervention studies in animals: After treatment with an antioxidant, all four studies showed an improvement in either markers of oxidative damage or antioxidant activity. One mouse study with a relatively low risk of bias showed that administration of acetylcysteine 200 mg/kg reduced malondialdehyde by 35% and increased survival by more than 60%.Antioxidant intervention studies in humans: We found two small randomised controlled trials reporting the use of acetylcysteine as an adjunct to standard treatment in acute OP poisoning. The trials found that acetylcysteine reduced atropine requirements by 77% and 55%, but did not affect clinically relevant outcomes.Conclusions: Several studies showed evidence of OP insecticide-induced oxidative damage and antioxidant activity, suggesting that endogenous antioxidant defences are triggered in acute OP poisoning. However, the markers of lipid peroxidation used were weak, there was high inter-individual variability between studies in results and quality, and marked variation between the OP insecticides involved. Animal data provide some evidence that antioxidants alleviate adverse effects of acute poisoning, suggesting that oxidative stress may directly cause clinical harm. Acetylcysteine appeared beneficial in animal studies, but this could be mediated via increased synthesis of the endogenous detoxifying agent, glutathione, rather than through a direct antioxidant effect. The two human clinical studies were too small to provide any clear evidence to support the use of acetylcysteine in OP poisoning. Further research into the mechanisms of oxidative stress in acute OP poisoning, combined with large unambiguous clinical trials of antioxidants, are required before they can be used routinely in treatment.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Rambabu L, Megson IL, Eddleston M, et al. Does oxidative stress contribute to toxicity in acute organophosphorus poisoning? - a systematic review of the evidence. Clin Toxicol (Phila). 2019. PMID: 31810386. doi:10.1080/15563650.2019.1693589

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。